Literature DB >> 32789848

Rheumatic heart disease anno 2020: Impacts of gender and migration on epidemiology and management.

Reuben K Mutagaywa1,2, Anna-Maria Wind2, Apolinary Kamuhabwa3, Maarten J Cramer2, Pilly Chillo1, Steven Chamuleau2,4.   

Abstract

BACKGROUND: The epidemiology and management of diseases can be influenced by social demographic factors. Gender and migration are among these factors.
METHODS: We aimed at reviewing the impacts of gender and migration on rheumatic heart disease (RHD) epidemiology and management by a nonsystematic literature review of published studies on RHD worldwide. Our PubMed search terms included RHD pathophysiology, diagnosis, complications, management or prevention, combined with words 'rheumatic mitral stenosis (MS)', 'outcomes after percutaneous balloon mitral valvuloplasty (PBMV)', 'gender or sex difference' and 'migration'. The reporting of this study conforms to SANRA (the Scale for Assessment of Narrative Review Articles) guidelines.
RESULTS: We retrieved eight studies about the impact of sex on outcomes after PBMV. All of these studies showed a female predominance for RHD. Two studies showed that there is no impact, three studies showed female sex as a predictor of poor outcomes, and the other three showed male sex a predictor of poor outcomes. Although RHD is reported to be eradicated in the developed countries, 2.1% of refugees recently screened for RHD in Italy were found to have subclinical RHD. This prevalence is similar to those found in India (2.0%), Cambodia (2.2%) and Mozambique (3%).
CONCLUSIONS: There are contradicting results for outcomes after PBMV between males and females. It is not clear whether sex difference plays a role in pathophysiology, diagnosis, management and prognosis of MS. Migration has impacts on epidemiology and management of RHD. Further studies are required in these two fields to explore their relationship to RHD.
© 2020 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  gender; impact; migration; review; rheumatic mitral stenosis; sex

Year:  2020        PMID: 32789848      PMCID: PMC7757241          DOI: 10.1111/eci.13374

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  63 in total

1.  Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.

Authors:  Alec Vahanian; Helmut Baumgartner; Jeroen Bax; Eric Butchart; Robert Dion; Gerasimos Filippatos; Frank Flachskampf; Roger Hall; Bernard Iung; Jaroslaw Kasprzak; Patrick Nataf; Pilar Tornos; Lucia Torracca; Arnold Wenink
Journal:  Eur Heart J       Date:  2007-01-26       Impact factor: 29.983

2.  Is mitral valve disease treated differently in men and women?

Authors:  Olga N Kislitsina; Karolina M Zareba; Robert O Bonow; Adin-Cristian Andrei; Jane Kruse; Jyothy Puthumana; Nausheen Akhter; S Chris Malaisrie; Patrick M McCarthy; Vera H Rigolin
Journal:  Eur J Prev Cardiol       Date:  2019-03-04       Impact factor: 7.804

3.  Difference in outcome among women and men after percutaneous mitral valvuloplasty.

Authors:  Ignacio Cruz-Gonzalez; Hani Jneid; Maria Sanchez-Ledesma; Roberto J Cubeddu; Javier Martin-Moreiras; Pablo Rengifo-Moreno; Tullio A Diaz; Thomas J Kiernan; Ignacio Inglessis-Azuaje; Andrew O Maree; Pedro L Sanchez; Igor F Palacios
Journal:  Catheter Cardiovasc Interv       Date:  2011-01-01       Impact factor: 2.692

4.  Healthcare coverage for undocumented migrants in Spain: Regional differences after Royal Decree Law 16/2012.

Authors:  Marta Cimas; Pedro Gullon; Eva Aguilera; Stefan Meyer; José Manuel Freire; Beatriz Perez-Gomez
Journal:  Health Policy       Date:  2016-02-17       Impact factor: 2.980

5.  2017 ESC/EACTS Guidelines for the management of valvular heart disease.

Authors:  Helmut Baumgartner; Volkmar Falk; Jeroen J Bax; Michele De Bonis; Christian Hamm; Per Johan Holm; Bernard Iung; Patrizio Lancellotti; Emmanuel Lansac; Daniel Rodriguez Muñoz; Raphael Rosenhek; Johan Sjögren; Pilar Tornos Mas; Alec Vahanian; Thomas Walther; Olaf Wendler; Stephan Windecker; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2017-09-21       Impact factor: 29.983

6.  Late results of percutaneous mitral commissurotomy in a series of 1024 patients. Analysis of late clinical deterioration: frequency, anatomic findings, and predictive factors.

Authors:  B Iung; E Garbarz; P Michaud; S Helou; B Farah; P Berdah; P L Michel; B Cormier; A Vahanian
Journal:  Circulation       Date:  1999-06-29       Impact factor: 29.690

7.  Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever.

Authors:  Christina Y Miyake; Kimberlee Gauvreau; Lloyd Y Tani; Robert P Sundel; Jane W Newburger
Journal:  Pediatrics       Date:  2007-09       Impact factor: 7.124

8.  What are the differences in presentation of candidates for percutaneous mitral commissurotomy across the world and do they influence the results of the procedure?

Authors:  Eloi Marijon; Bernard Iung; Ana-Olga Mocumbi; Joël Kamblock; Chien Vo Thanh; Habib Gamra; Cesar Esteves; Igor F Palacios; Alec Vahanian
Journal:  Arch Cardiovasc Dis       Date:  2008-11-21       Impact factor: 2.340

9.  The age-specific clinical and anatomical profile of mitral stenosis.

Authors:  C D Ramakrishna; S A Khadar; R George; V L Jayaprakash; N Sudhayakumar; K Jayaprakash; J M Pappachan
Journal:  Singapore Med J       Date:  2009-07       Impact factor: 1.858

10.  Screening of asymptomatic rheumatic heart disease among refugee/migrant children and youths in Italy.

Authors:  Fortunata Condemi; Gabriele Rossi; Miguel Lupiz; Antonio Pagano; Federica Zamatto; Stefano Marini; Francesco Romeo; Gianfranco De Maio
Journal:  Pediatr Rheumatol Online J       Date:  2019-04-02       Impact factor: 3.054

View more
  8 in total

Review 1.  Sex Differences and Similarities in Valvular Heart Disease.

Authors:  Jacqueline T DesJardin; Joanna Chikwe; Rebecca T Hahn; Judy W Hung; Francesca N Delling
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 17.367

2.  Global burden of rheumatic heart disease: trends from 1990 to 2019.

Authors:  Zejin Ou; Danfeng Yu; Yuanhao Liang; Jinhua Wu; Huan He; Yongzhi Li; Wenqiao He; Yuhan Gao; Fei Wu; Qing Chen
Journal:  Arthritis Res Ther       Date:  2022-06-11       Impact factor: 5.606

3.  Awareness of rheumatic fever and rheumatic heart disease among the population in taif, Saudi Arabia 2020.

Authors:  Mohammed M Mougrabi; Raghad Sami Aljuaid; Aeshah Dakhel Alrabie; Nouran Khalid Althumali; Lama Humaied Alkhaldi; Waad Dhaifallah Alotaibi
Journal:  J Family Med Prim Care       Date:  2021-08-27

4.  Predicting ICU Mortality in Rheumatic Heart Disease: Comparison of XGBoost and Logistic Regression.

Authors:  Yixian Xu; Didi Han; Tao Huang; Xiaoshen Zhang; Hua Lu; Si Shen; Jun Lyu; Hao Wang
Journal:  Front Cardiovasc Med       Date:  2022-02-28

5.  Contemporary prevalence and outcomes of rheumatic mitral valve surgery.

Authors:  Robert B Hawkins; Raymond J Strobel; J Hunter Mehaffey; Mohammed A Quader; Mark Joseph; Gorav Ailawadi
Journal:  J Card Surg       Date:  2022-02-26       Impact factor: 1.778

6.  Enlargement of the Left Atrium Strongly Predicts Postoperative Mortality Following Heart Valve Surgery.

Authors:  Khalid S Ibrahim; Khalid A Kheirallah; Mahmoud A Megdadi
Journal:  Vasc Health Risk Manag       Date:  2022-09-30

Review 7.  Infective endocarditis in developing countries: An update.

Authors:  Reuben K Mutagaywa; Josephine C Vroon; Lulu Fundikira; Anna Maria Wind; Peter Kunambi; Joel Manyahi; Apollinary Kamuhabwa; Gideon Kwesigabo; Steven A J Chamuleau; Maarten J Cramer; Pilly Chillo
Journal:  Front Cardiovasc Med       Date:  2022-09-12

Review 8.  Rheumatic heart disease anno 2020: Impacts of gender and migration on epidemiology and management.

Authors:  Reuben K Mutagaywa; Anna-Maria Wind; Apolinary Kamuhabwa; Maarten J Cramer; Pilly Chillo; Steven Chamuleau
Journal:  Eur J Clin Invest       Date:  2020-08-29       Impact factor: 4.686

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.